Article Versions Notes

Lux MP, Nabieva N, Hartkopf AD, Huober J, Volz B, Taran F-A, Overkamp F, Kolberg H-C, Hadji P, Tesch H, et al. Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry. Cancers. 2019; 11(1):10. https://doi.org/10.3390/cancers11010010

Lux, Michael P., Naiba Nabieva, Andreas D. Hartkopf, Jens Huober, Bernhard Volz, Florin-Andrei Taran, Friedrich Overkamp, Hans-Christian Kolberg, Peyman Hadji, Hans Tesch, and et al. 2019. "Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry" Cancers 11, no. 1: 10. https://doi.org/10.3390/cancers11010010

Lux, M. P., Nabieva, N., Hartkopf, A. D., Huober, J., Volz, B., Taran, F. -A., Overkamp, F., Kolberg, H. -C., Hadji, P., Tesch, H., Häberle, L., Ettl, J., Lüftner, D., Wallwiener, M., Müller, V., Beckmann, M. W., Belleville, E., Wimberger, P., Hielscher, C., ... Brucker, S. Y. (2019). Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry. Cancers, 11(1), 10. https://doi.org/10.3390/cancers11010010